Introduction. Auditory hallucinations are a common symptom experience of individuals with psychotic disorders and are often experienced as persistent, distressing, and disruptive. This case series examined the lived experiences of four individuals treated (successfully or unsuccessfully) with low-frequency (1？Hz) rTMS for auditory hallucinations. Methods. A phenomenological approach was used and modified to involve some predetermined data structuring to accommodate for expected cognitive impairments of participants and the impact of rTMS on auditory hallucinations. Data on thoughts and feelings in relation to the helpful, unhelpful, and other effects of rTMS on auditory hallucinations, on well-being, functioning, and the immediate environment were collected using semistructured interviews. Results. All four participants noted some improvements in their well-being following treatment and none reported a worsening of their symptoms. Only two participants noted an improvement in the auditory hallucinations and only one of them reported an improvement that was sustained after treatment completion. Conclusion. We suggest that there are useful findings in the study worth further exploration, specifically in relation to the role of an individual’s acceptance and ownership of the illness process in relation to this biomedical intervention. More mixed methods research is required to examine rTMS for auditory hallucinations. 1. Introduction Auditory hallucinations, that is, the experience of sound in the absence of external perceptual stimuli, are a common symptom of individuals with psychotic disorders such as schizophrenia and schizoaffective disorder. The prevalence of auditory hallucinations in schizophrenia is reported to be 75% [1]. Many of these individuals experience auditory hallucinations as persistent, distressing, and disruptive. Up to 30% of individuals with auditory hallucinations respond only partially or not at all to standard antipsychotic treatment [2, 3]. Shergill et al. [4] concluded in their review of psychological treatments for auditory hallucinations that, although these are of some benefit, they often result in improvement in the auditory hallucinations-associated distress, or control over the experience, rather than in elimination or reduction in auditory hallucinations. Low-frequency (1？Hz) repetitive transcranial magnetic stimulation (rTMS) in the left temporoparietal cortex (TPC) has been used for the treatment of refractory auditory hallucinations, with some success. This area has been targeted because previous neuroimaging research
References
[1]
T. H. Nayani and A. S. David, “The auditory hallucination: a phenomenological survey,” Psychological Medicine, vol. 26, no. 1, pp. 177–189, 1996.
[2]
J. Kane, G. Honigfeld, J. Singer, and H. Meltzer, “Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine,” Archives of General Psychiatry, vol. 45, no. 9, pp. 789–796, 1988.
[3]
H. Y. Meltzer, “Treatment of the neuroleptic-nonresponsive schizophrenic patient,” Schizophrenia Bulletin, vol. 18, no. 3, pp. 515–542, 1992.
[4]
S. S. Shergill, R. M. Murray, and P. K. McGuire, “Auditory hallucinations: a review of psychological treatments,” Schizophrenia Research, vol. 32, no. 3, pp. 137–150, 1998.
[5]
R. E. Hoffman, K. A. Hawkins, R. Gueorguieva et al., “Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations,” Archives of General Psychiatry, vol. 60, no. 1, pp. 49–56, 2003.
[6]
A. Vercammen, H. Knegtering, R. Bruggeman et al., “Effects of bilateral repetitive transcranial magnetic stimulation on treatment resistant auditory-verbal hallucinations in schizophrenia: a randomized controlled trial,” Schizophrenia Research, vol. 114, no. 1–3, pp. 172–179, 2009.
[7]
A. Vercammen, H. Knegtering, E. J. Liemburg, J. A. D. Boer, and A. Aleman, “Functional connectivity of the temporo-parietal region in schizophrenia: effects of rTMS treatment of auditory hallucinations,” Journal of Psychiatric Research, vol. 44, no. 11, pp. 725–731, 2010.
[8]
P. M. Gromann, D. K. Tracy, V. Giampietro, M. J. Brammer, L. Krabbendam, and S. S. Shergill, “Examining frontotemporal connectivity and rTMS in healthy controls: implications for auditory hallucinations in schizophrenia,” Neuropsych, vol. 26, no. 1, pp. 127–132, 2012.
[9]
C. Freitas, F. Fregni, and A. Pascual-Leone, “Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia,” Schizophrenia Research, vol. 108, no. 1–3, pp. 11–24, 2009.
[10]
C. W. Slotema, A. Aleman, Z. J. Daskalakis, and I. E. Sommer, “Meta-analysis of repetitive transcranial magnetic stimulation in the treatment of auditory verbal hallucinations: update and effects after one month,” Schizophrenia Research, no. 1–3, pp. 40–45, 2012.
[11]
J. W. Creswell, Qualitative Inquiry and Research Design: Choosing among Five Approaches, Sage Publications, Thousand Oaks, Calif, USA, 2007.
[12]
R. C. Aitken, “Measurement of feelings using visual analogue scales,” Proceedings of the Royal Society of Medicine, vol. 62, no. 10, pp. 989–993, 1969.
[13]
C. Tranulis, A. A. Sepehry, A. Galinowski, and E. Stip, “Should we treat auditory hallucinations with repetitive transcranial magnetic stimulation? A metaanalysis,” Canadian Journal of Psychiatry, vol. 53, no. 9, pp. 577–586, 2008.
[14]
R. K. Yin, Case Study Research: design and Methods, Sage Publications, Thousand Oaks, Calif, USA, 2009.
[15]
E. Poulet, F. Haesebaert, M. Saoud, M. F. Suaud-Chagny, and J. Brunelin, “Treatment of shizophrenic patients and rTMS,” Psychiatria Danubina, vol. 22, no. 1, pp. S143–S146, 2010.
[16]
J. Stokes, D. Pogge, B. Wecksell, and M. Zaccario, “Parent-child discrepancies in report of psychopathology: the contributions of response bias and parenting stress,” Journal of Personality Assessment, vol. 93, no. 5, pp. 527–536, 2011.
[17]
B. E. H. Schorre and I. H. Vandvik, “Global assessment of psychosocial functioning in child and adolescent psychiatry: a review of three unidimensional scales (CGAS, GAF, GAPD),” European Child and Adolescent Psychiatry, vol. 13, no. 5, pp. 273–286, 2004.
[18]
R. J. Keuneman, V. Pokos, R. Weerasundera, and D. J. Castle, “Antipsychotic treatment in obsessive-compulsive disorder: a literature review,” Australian and New Zealand Journal of Psychiatry, vol. 39, no. 5, pp. 336–343, 2005.
[19]
Y. Levkovitch, Y. Kronnenberg, and B. Gaoni, “Can clozapine trigger OCD?” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 34, no. 3, p. 263, 1995.
[20]
W. K. Goodman, C. J. McDougle, L. H. Price, M. A. Riddle, D. L. Pauls, and J. F. Leckman, “Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?” Journal of Clinical Psychiatry, vol. 51, no. 8, pp. 36–43, 1990.
[21]
C. W. Slotema, J. D. Blom, H. W. Hoek, and I. E. C. Sommer, “Should we expand the toolbox of psychiatric treatment methods to include repetitive transcranial magnetic stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders,” Journal of Clinical Psychiatry, vol. 71, no. 7, pp. 873–884, 2010.
[22]
P. B. Fitzgerald, S. Herring, K. Hoy et al., “A study of the effectiveness of bilateral transcranial magnetic stimulation in the treatment of the negative symptoms of schizophrenia,” Brain Stimulation, vol. 1, no. 1, pp. 27–32, 2008.
[23]
A. Mogg, R. Purvis, S. Eranti et al., “Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: a randomized controlled pilot study,” Schizophrenia Research, vol. 93, no. 1–3, pp. 221–228, 2007.
[24]
R. Prikryl, T. Kasparek, S. Skotakova, L. Ustohal, H. Kucerova, and E. Ceskova, “Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study,” Schizophrenia Research, vol. 95, no. 1–3, pp. 151–157, 2007.
[25]
E. Klein, Y. Kolsky, M. Puyerovsky, D. Koren, A. Chistyakov, and M. Feinsod, “Right prefrontal slow repetitive transcranial magnetic stimulation in schizophrenia: a double-blind sham-controlled pilot study,” Biological Psychiatry, vol. 46, no. 10, pp. 1451–1454, 1999.
[26]
P. Alonso, J. Pujol, N. Cardoner et al., “Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a double-blind, placebo-controlled study,” American Journal of Psychiatry, vol. 158, no. 7, pp. 1143–1145, 2001.
[27]
J. Pra？ko, B. Pa？ková, R. Zálesky et al., “The effect of repetitive transcranial magnetic stimulation (rTMS) on symptoms in obsessive compulsive disorder. A randomized, double blind, sham controlled study,” Neuroendocrinology Letters, vol. 27, no. 3, pp. 327–332, 2006.
[28]
P. S. Sachdev, C. K. Loo, P. B. Mitchell, T. F. McFarquhar, and G. S. Malhi, “Repetitive transcranial magnetic stimulation for the treatment of obsessive compulsive disorder: a double-blind controlled investigation,” Psychological Medicine, vol. 37, no. 11, pp. 1645–1649, 2007.
[29]
D. Roe, M. Chopra, and A. Rudnick, “Persons with psychosis as active agents interacting with their disorder,” Psychiatric Rehabilitation Journal, vol. 28, no. 2, pp. 122–128, 2004.
[30]
J. Hamann, B. Neuner, J. Kasper et al., “Participation preferences of patients with acute and chronic conditions,” Health Expectations, vol. 10, no. 4, pp. 358–363, 2007.
